Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response

Prophylactic hepatitis C virus (HCV) vaccine trials with human volunteers are pending. There is an important need for immunological end points which correlate with vaccine efficacy and which do not involve invasive procedures, such as liver biopsies. By using a multicomponent DNA priming-protein boo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Virol
Autores principales: Rollier, C., Depla, E., Drexhage, J. A. R., Verschoor, E. J., Verstrepen, B. E., Fatmi, A., Brinster, C., Fournillier, A., Whelan, J. A., Whelan, M., Jacobs, D., Maertens, G., Inchauspé, G., Heeney, J. L.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2004
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303385/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14671100/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.1.187-196.2004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares